Cautious. Oscar Health shows solid growth fundamentals (Growth Compounder 62.7, 27.3× forward P/E) but faces acute policy risk: 97% of direct premiums depend on federal Advanced Premium Tax Credits (APTCs), creating structural vulnerability to subsidy changes. Leadership alignment is weak (47.5/100), and regulatory dependence on ACA compliance limits strategic flexibility—attractive growth cannot offset these material tail risks.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Oscar Health, Inc.:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 59/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates Oscar Health, Inc. (OSCR) at 59/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. Oscar Health shows solid growth fundamentals (Growth Compounder 62.7, 27.3× forward P/E) but faces acute policy risk: 97% of direct premiums depend on federal Advanced Premium Tax Credits (APTCs), creating structural vulnerability
OSCR's current Stocky Verdict is 59/100, placing it in the "Cautious" band. This composite combines a 63/100 Compounder score, 48/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for Oscar Health, Inc. yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
Oscar Health, Inc. scores 48/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
Oscar Health, Inc.'s Vulnerability Profile scores 83/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Oscar Health, Inc..
Sign up free and unlock the full analysis on OSCR — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
Or jump straight to the interactive dashboard for OSCR in the app.
